Evidence map›Paper›PMID 34629890›Full record

ArticlePharmacogenomics and personalized medicine2021

Aswin Anand Pai, Ajith Mohan, Esther Sathya Bama Benjamin, Raveen Stephen Stallon Illangeswaran, Infencia Xavier Raj, Nancy Beryl Janet, Arun Kumar Arunachalam, M L Kavitha, Uday Kulkarni, Anup J Devasia and 7 more

Open access · goldAbstract read
In one paragraph

Article in Pharmacogenomics and personalized medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Association ofHaematologica · 2024
    Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Aswin Anand PaiDepartment of Haematology, Christian Medical College, Vellore, Tamilnadu, India.
Ajith MohanDepartment of Haematology, Christian Medical College, Vellore, Tamilnadu, India.ORCID 0000-0002-3891-8517
Esther Sathya Bama BenjaminDepartment of Haematology, Christian Medical College, Vellore, Tamilnadu, India.
Raveen Stephen Stallon IllangeswaranDepartment of Haematology, Christian Medical College, Vellore, Tamilnadu, India.
Infencia Xavier RajDepartment of Haematology, Christian Medical College, Vellore, Tamilnadu, India.
Nancy Beryl JanetDepartment of Haematology, Christian Medical College, Vellore, Tamilnadu, India.
Arun Kumar ArunachalamDepartment of Haematology, Christian Medical College, Vellore, Tamilnadu, India.ORCID 0000-0002-0362-0278
M L KavithaDepartment of Haematology, Christian Medical College, Vellore, Tamilnadu, India.
Uday KulkarniDepartment of Haematology, Christian Medical College, Vellore, Tamilnadu, India.
Anup J DevasiaDepartment of Haematology, Christian Medical College, Vellore, Tamilnadu, India.
N A FouziaDepartment of Haematology, Christian Medical College, Vellore, Tamilnadu, India.
Aby AbrahamDepartment of Haematology, Christian Medical College, Vellore, Tamilnadu, India.
Alok SrivastavaDepartment of Haematology, Christian Medical College, Vellore, Tamilnadu, India.
Biju GeorgeDepartment of Haematology, Christian Medical College, Vellore, Tamilnadu, India.
Vikram MathewsDepartment of Haematology, Christian Medical College, Vellore, Tamilnadu, India.
Anu KorulaDepartment of Haematology, Christian Medical College, Vellore, Tamilnadu, India.
Poonkuzhali BalasubramanianDepartment of Haematology, Christian Medical College, Vellore, Tamilnadu, India.ORCID 0000-0002-9443-439X
Christian Medical College, Vellore · IN

Funding

DBT-Wellcome Trust India Alliance IA/CPHE/17/1/503351DBT-Wellcome Trust India Alliance IA/CPHS/18/1/503930DBT-Wellcome Trust India Alliance IA/S/15/1/501842Wellcome Trust
6 · The paper itself

Abstract

purposeSevere myelosuppression in patients with acute lymphoblastic leukemia (ALL) undergoing 6-MP-based maintenance therapy is attributed to PATIENTS AND

methodsWe screened for the presence of

resultsNineteen (45%) patients in cohort-1 and 18 (14%) in cohort-2 had

conclusion

Indexed as

leukemiamercaptopurinemyelotoxicitypharmacogenomics

Identifiers

PMID34629890
PMCPMC8495143
OpenAlexW3204558633

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.